Variant Gene Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs104894098
rs104894098
0.800 SusceptibilityMutation CLINVAR CDKN2A mutations and melanoma risk in the Icelandic population. 18178632

2008

dbSNP: rs104894099
rs104894099
0.800 SusceptibilityMutation CLINVAR A single Mediterranean, possibly Jewish, origin for the Val59Gly CDKN2A mutation in four melanoma-prone families. 12700603

2003

dbSNP: rs113798404
rs113798404
0.800 SusceptibilityMutation CLINVAR Germline mutation of ARF in a melanoma kindred. 12019208

2002

dbSNP: rs113798404
rs113798404
0.800 GeneticVariation UNIPROT Germline mutation of ARF in a melanoma kindred. 12019208

2002

dbSNP: rs104894098
rs104894098
0.800 GeneticVariation UNIPROT A common founder for the V126D CDKN2A mutation in seven North American melanoma-prone families. 11506491

2001

dbSNP: rs104894099
rs104894099
0.800 GeneticVariation UNIPROT CDKN2A mutations in Spanish cutaneous malignant melanoma families and patients with multiple melanomas and other neoplasia. 10874641

2000

dbSNP: rs104894099
rs104894099
0.800 SusceptibilityMutation CLINVAR CDKN2A mutations in Spanish cutaneous malignant melanoma families and patients with multiple melanomas and other neoplasia. 10874641

2000

dbSNP: rs104894095
rs104894095
0.800 SusceptibilityMutation CLINVAR Haplotype analysis of two recurrent CDKN2A mutations in 10 melanoma families: evidence for common founders and independent mutations. 9603434

1998

dbSNP: rs104894095
rs104894095
0.800 SusceptibilityMutation CLINVAR CDKN2A germline mutations in U.K. patients with familial melanoma and multiple primary melanomas. 9699728

1998

dbSNP: rs104894095
rs104894095
0.800 SusceptibilityMutation CLINVAR CDKN2A mutations in multiple primary melanomas. 9516223

1998

dbSNP: rs104894097
rs104894097
0.800 SusceptibilityMutation CLINVAR CDKN2A mutations in multiple primary melanomas. 9516223

1998

dbSNP: rs104894097
rs104894097
0.800 SusceptibilityMutation CLINVAR CDKN2A germline mutations in U.K. patients with familial melanoma and multiple primary melanomas. 9699728

1998

dbSNP: rs104894099
rs104894099
0.800 SusceptibilityMutation CLINVAR Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group. 9425228

1998

dbSNP: rs104894095
rs104894095
0.800 GeneticVariation UNIPROT Germline mutations of the CDKN2 gene in UK melanoma families. 9328469

1997

dbSNP: rs104894095
rs104894095
0.800 SusceptibilityMutation CLINVAR Germline mutations of the CDKN2 gene in UK melanoma families. 9328469

1997

dbSNP: rs104894097
rs104894097
0.800 GeneticVariation UNIPROT Germline mutations of the CDKN2 gene in UK melanoma families. 9328469

1997

dbSNP: rs104894095
rs104894095
0.800 GeneticVariation UNIPROT Mutations of the CDKN2/p16INK4 gene in Australian melanoma kindreds. 8595405

1996

dbSNP: rs104894095
rs104894095
0.800 GeneticVariation UNIPROT Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population. 8710906

1996

dbSNP: rs104894098
rs104894098
0.800 GeneticVariation UNIPROT Mutations associated with familial melanoma impair p16INK4 function. 7647780

1995

dbSNP: rs104894098
rs104894098
0.800 GeneticVariation UNIPROT Germline p16 mutations in familial melanoma. 7987387

1995

dbSNP: rs137854597
rs137854597
0.800 SusceptibilityMutation CLINVAR A cell cycle regulator potentially involved in genesis of many tumor types. 8153634

1994

dbSNP: rs137854597
rs137854597
0.800 GeneticVariation UNIPROT

dbSNP: rs587776716
rs587776716
0.700 SusceptibilityMutation CLINVAR Indication for CDKN2A-mutation analysis in familial pancreatic cancer families without melanomas. 22636603

2013

dbSNP: rs587780668
rs587780668
0.700 SusceptibilityMutation CLINVAR Predicting functional significance of cancer-associated p16(INK4a) mutations in CDKN2A. 20340136

2010

dbSNP: rs758389471
rs758389471
0.700 GeneticVariation UNIPROT Functional, structural, and genetic evaluation of 20 CDKN2A germ line mutations identified in melanoma-prone families or patients. 19260062

2009